Navigation Links
Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
Date:11/12/2008

pectrum includes class A (including ESBL and KPC) and class C enzymes. NXL104 in combination with ceftazidime will be targeting infections caused by Gram negative bacteria, including Enterobacteriaceae and Pseudomonas.

About Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The ever increasing resistance to marketed antibiotics has led to a clear need for novel drugs that are active against multi-drug resistant bacteria. Novexel's products are targeting the global hospital antibiotic market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database.

Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalosporin antibiotic ceftazidime for serious Gram negative infections, and the oral streptogramin antibiotic, NXL103, for the treatment of Gram positive infections, with a focus on treatment in the hospital setting and intravenous (IV) to oral switch. Novexel has three further programmes in preclinical development, NXL105, a novel anti-Pseudomonal antibiotic, NXL201, a novel echinocandin antifungal agent, and NXL104 in combination with ceftaroline. This latter product is being developed by our partner, Forest Laboratories, solely for North American markets.

Novexel was created in December 2004 as an independent spin-out of the sanofi-aventis (Euronext Paris: SAN, NYSE: SNY) anti-infectives unit. Novexel has a team of 50 employees with significant experience in anti-infective research and development, who are located in Paris, France and Philadelphia, USA.

---------------------------------

(i) USA: HCUPnet; France, Agence technique de l'Information sur

l'Hospitalisation ; UK The Informatio
'/>"/>

SOURCE Novexel
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
2. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
3. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
4. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
5. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
6. Particle Sciences Expands Its Combination Product Capabilities
7. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
8. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
10. Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma
11. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... , April 28, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets patented products that ... diseases, today announced that it has received an order ... in the country who offer Medicare Advantage programs. This ... 15 insurance plans who are now customers of Semler. ...
(Date:4/28/2015)... , April 28, 2015  Olympus, a precision technology ... and surgical procedures, among other core businesses, announced today ... Brooklyn Park, MN. The new ... designed to position the company for continued long-term growth ... dedication ceremony took place on April 27 and was ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4
(Date:4/28/2015)... New and more complex medicines offer ... payers, pharmacists and patients. Now Specialty Pharmacy Times, ... with the National Association of Specialty Pharmacy (NASP), ... this developing field to better equip pharmacy businesses ... “This partnership creates a powerful platform for getting ...
(Date:4/28/2015)... Hellen Chen, who is a bestselling author and ... to a study conducted by Washington University, between ... has increased by 20% while the number of unfaithful husbands ... report released this year from the Journal of ... or both spouses admit to infidelity, either physical or emotional ...
(Date:4/28/2015)... Angeles, CA (PRWEB) April 28, 2015 ... is 2.9 out of 5, indicating a medium ... power means buyers and suppliers have equal power during ... of substitutes. Rather than purchasing a health insurance policy ... Cigna Corporation or Humana), buyers can choose to self-fund ...
(Date:4/28/2015)... Memphis, Tennessee (PRWEB) April 28, 2015 ... FDA-approved modular system for two-stage revision of infected ... REMEDY® Spacer is sterile-packaged as a pre-formed, pre-loaded ... elution to the infected joint space. Combined ... articulating surfaces, the REMEDY® spacer is approved for ...
(Date:4/28/2015)... Saint Louis, MO (PRWEB) April 28, 2015 ... May 6, 2015 from 5:00 to 8:00 pm at the ... 01880. More than 50 hospitals, clinics and groups with career ... will be represented. Attendees will enjoy free hors d’oeuvres and ... for PracticeMatch says “Boston is an ideal location ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3
... with mild cognitive impairment revealed that results from cognitive ... warning system for the subsequent development of Alzheimer,s disease. ... the study with mild cognitive impairment, those with low ... metabolism in particular brain regions, as detected through positron ...
... ... is, at Kirkland Uncorked a festival of art, style and taste July 17-19 in Marina Park. ... Kirkland, WA (Vocus) June 26, 2009 ... that is, at Kirkland Uncorked a festival of art, style and taste July 17-19 ...
... nearly two-decade effort to,treat people living with HIV ... the epidemic. Inexpensive generic medicines are a large,part ... and the Harvard,School of Public Health., Brazil did ... prompted pharmaceutical companies with exclusive drugs to,lower their ...
... N.C. Simulating medical scenarios helps medical students learn ... done by researchers at Wake Forest University School of ... Teacher , shows that medical students not only enjoy ... Michael T. Fitch, M.D., Ph.D., the senior author of ...
... Integrate Primary and Specialty Care to Improve the Quality ... of commentaries to understand health and healthcare, With the ... Annals of Family Medicine editor Kurt Stange, M.D., ... help make sense of the problems and opportunities we ...
... , DENVER, July 13 DaVita Inc. ... for those diagnosed with chronic kidney disease (CKD), today announced Mahesh Krishnan, ... for Research, effective July 13, 2009. , , ... DaVita Clinical Research is recognized as a leader in clinical trials for ...
Cached Medicine News:Health News:Memory test and PET scans detect early signs of Alzheimer's 2Health News:Memory test and PET scans detect early signs of Alzheimer's 3Health News:Drinking Wine Is Good For The "Heart" & Environment 2Health News:Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic 2Health News:Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic 3Health News:Simulating medical situations helps students learn, retain basic science concepts 2Health News:July/August 2009 Annals of Family Medicine tip sheet 2Health News:July/August 2009 Annals of Family Medicine tip sheet 3Health News:July/August 2009 Annals of Family Medicine tip sheet 4Health News:July/August 2009 Annals of Family Medicine tip sheet 5Health News:July/August 2009 Annals of Family Medicine tip sheet 6Health News:July/August 2009 Annals of Family Medicine tip sheet 7Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 2Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: